scholarly journals Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy

2008 ◽  
Vol 14 (5) ◽  
pp. 455-458 ◽  
Author(s):  
Angela Marzocchetti ◽  
Christian Wuthrich ◽  
Chen S Tan ◽  
Troy Tompkins ◽  
Francisco Bernal-Cano ◽  
...  
1998 ◽  
Vol 18 (3) ◽  
pp. 347-351 ◽  
Author(s):  
Yosuke Wakutani ◽  
Yasutaka Shimizu ◽  
Hiroshi Miura ◽  
Kenji Nakashima ◽  
Toshiya Nakano ◽  
...  

2010 ◽  
Vol 84 (18) ◽  
pp. 9200-9209 ◽  
Author(s):  
Chen S. Tan ◽  
Laura C. Ellis ◽  
Christian Wüthrich ◽  
Long Ngo ◽  
Thomas A. Broge ◽  
...  

ABSTRACT JC virus (JCV) is latent in the kidneys and lymphoid organs of healthy individuals, and its reactivation in the context of immunosuppression may lead to progressive multifocal leukoencephalopathy (PML). Whether JCV is present in the brains or other organs of healthy people and in immunosuppressed patients without PML has been a matter of debate. We detected JCV large T DNA by quantitative PCR of archival brain samples of 9/24 (38%) HIV-positive PML patients, 5/18 (28%) HIV-positive individuals, and 5/19 (26%) HIV-negative individuals. In the same samples, we detected JCV regulatory region DNA by nested PCR in 6/19 (32%) HIV-positive PML patients, 2/11 (18%) HIV-positive individuals, and 3/17 (18%) HIV-negative individuals. In addition, JCV DNA was detected in some spleen, lymph node, bone, and kidney samples from the same groups. In situ hybridization data confirmed the presence of JCV DNA in the brains of patients without PML. However, JCV proteins (VP1 or T antigen) were detected mainly in the brains of 23/24 HIV-positive PML patients, in only a few kidney samples of HIV-positive patients, with or without PML, and rarely in the bones of HIV-positive patients with PML. JCV proteins were not detected in the spleen or lymph nodes in any study group. Furthermore, analysis of the JCV regulatory region sequences showed both rearranged and archetype forms in brain and extraneural organs in all three study groups. Regulatory regions contained increased variations of rearrangements correlating with immunosuppression. These results provide evidence of JCV latency in the brain prior to severe immunosuppression and suggest new paradigms in JCV latency, compartmentalization, and reactivation.


2001 ◽  
Vol 75 (12) ◽  
pp. 5672-5676 ◽  
Author(s):  
Luz-Andrea Pfister ◽  
Norman L. Letvin ◽  
Igor J. Koralnik

ABSTRACT JC virus (JCV), the causative agent of progressive multifocal leukoencephalopathy (PML), has a hypervariable regulatory region (JCV RR). A conserved archetype form is found in the urines of healthy and immunocompromised individuals, whereas forms with tandem repeats and deletions are found in the brains of PML patients. Type I JCV RR, seen in MAD-1, the first sequenced strain of JCV, contains two 98-bp tandem repeats each containing a TATA box. Type II JCV RR has additional 23-bp and 66-bp inserts or fragments thereof and only one TATA box. We cloned and sequenced JCV RR from different anatomic compartments of PML patients and controls and correlated our findings with the patients' clinical outcome. Twenty-three different sequences were defined in 198 clones obtained from 16 patients. All 104 clones with tandem repeats were type II JCV RR. Patients with poor clinical outcome had high proportions of JCV RR clones with both tandem repeats in plasma (54%) and brain or cerebrospinal fluid (85%). In those who became survivors of PML, archetype sequences predominated in these anatomic compartments (75 and 100%, respectively). In patients with advanced human immunodeficiency virus infection without PML, only 8% of JCV RR clones obtained in the plasma contained tandem repeats. These data suggest that the presence of tandem repeats in plasma and CNS JCV RR clones is associated with poor clinical outcome in patients with PML.


1988 ◽  
Vol 318 (5) ◽  
pp. 301-305 ◽  
Author(s):  
Sidney A. Houff ◽  
Eugene O. Major ◽  
David A. Katz ◽  
Conrad V. Kufta ◽  
John L. Sever ◽  
...  

2005 ◽  
Vol 79 (3) ◽  
pp. 1361-1366 ◽  
Author(s):  
Xin Dang ◽  
Michael K. Axthelm ◽  
Norman L. Letvin ◽  
Igor J. Koralnik

ABSTRACT Rearrangements of the JC virus (JCV) regulatory region (RR) are consistently found in the brains of patients with progressive multifocal leukoencephalopathy (PML), whereas the archetype RR is present in their kidneys. In addition, the C terminus of the large T antigen (T-Ag) shows greater variability in PML than does the rest of the coding region. To determine whether similar changes in simian virus 40 (SV40) are necessary for disease induction in monkeys, we sequenced the SV40 RR and the C terminus of the T-Ag from the brain of simian/human immunodeficiency virus (SHIV)-infected monkey 18429, which presented spontaneously with an SV40-associated PML-like disease, as well as from the peripheral blood mononuclear cells (PBMC), kidneys, and brains of SV40-seronegative, SHIV-infected monkeys 21289 and 21306, which were inoculated with the 18429 brain SV40 isolate. These animals developed both SV40-associated PML and meningoencephalitis. Thirteen types of SV40 RR were characterized. Compared to the SV40 archetype, we identified RRs with variable deletions in either the origin of replication, the 21-bp repeat elements, or the late promoter, as well as deletions or duplications of the 72-bp enhancer. The archetype was the most prominent RR in the brain of monkey 18429. Shortly after inoculation, a wide range of RRs could be found in the PBMC of monkeys 21289 and 21306. However, the archetype RR became the predominant type in their blood, kidneys, and brains at the time of sacrifice. On the contrary, the T-Ag C termini remained identical in all compartments of the three animals. These results indicate that unlike JCV in humans, rearrangements of SV40 RR are not required for brain disease induction in immunosuppressed monkeys.


2009 ◽  
Vol 133 (5) ◽  
pp. 766-774
Author(s):  
Renzo Boldorini ◽  
Sara Allegrini ◽  
Umberto Miglio ◽  
Alessia Paganotti ◽  
Claudia Veggiani

Abstract Context.—BK virus strains or regulatory region sequence variations may play a role in the pathogenesis of polyomavirus-associated nephropathy (PVAN), although no definite relationship has yet been demonstrated. Objective.—To investigate the pathologic significance of BK virus strains and regulatory region sequence variations. Design.—Eight (3.5%) of 226 patients with renal transplants developed PVAN; the remaining 218 cases were used as controls. From the patients who developed PVAN, 70 urine samples, 63 blood samples, and 17 renal biopsy samples were taken, and 682 urine samples, 677 blood samples, and 101 renal biopsy samples were taken from the control cases. Amplification and sequence analyses of regulatory region were obtained, and the sequences were analyzed using the Basic Local Alignment Search Tool program. Results.—The WWT strain was more frequently detected in PVAN cases than in the control cases (urine: 88.5% vs 22.1%; blood: 85.2% vs 40%; renal biopsies: 77.8% vs 0%), and the AS and WW strains were only isolated from controls. Strain 128-1 was frequently associated with JC virus coinfection in both groups (PVAN: 78.3%; controls: 98%). Major WWT rearrangements were detected in 29.6% of the urine samples, 30.4% of the blood samples, and one renal biopsy from the PVAN cases, but in only one urine sample from the controls. Insertion of 8 base pairs (P block) was found in all 128-1 strains; WW and AS were archetypal in 78.9% and 57.7% of the samples, respectively. Conclusions.—Although the study included only 8 PVAN cases, regulatory region sequence variations seem to be frequent and independent of the development of the disease, and the WWT strain seems more frequently related to the development of nephropathy than other strains.


2019 ◽  
Vol 25 (4) ◽  
pp. 475-479
Author(s):  
Eugene Mubanga ◽  
Atiyah Patel ◽  
Omar K. Siddiqi ◽  
Barbara A. Hanson ◽  
Xin Dang ◽  
...  

2018 ◽  
Vol 56 (4) ◽  
pp. 519-524
Author(s):  
I. B. Bashkova ◽  
I. V. Madyanov ◽  
M. S. Shostak ◽  
T. V. Prokopyeva

When rheumatoid arthritis (RA) is treated with rituximab (RTM), there may be various adverse events, among which progressive multifocal leukoencephalopathy (PML) occupies a special place. The disease is caused by activation of opportunistic viral (JC-virus) infection in the presence of weakened cellular immunity, which leads to massive demyelination of brain structures. The paper describes a clinical case of using RTM in a female patient with RA with systemic manifestations. This treatment was effective during two years, but multifocal brain damage characteristic of PML developed after the last (fourth) cycle of infusions. Differential diagnosis with other diseases accompanied by similar brain changes allowed the authors to regard PML as the most likely diagnosis in this patient despite the negative result of determining JC virus DNA in blood and spinal fluid. The chosen therapy policy (a reduced dose of glucocorticoids, the use of a serotonin reuptake inhibitor, the antidepressant mirtazapine, and therapeutic plasmapheresis) with regard for presumed PML the patient has been proven to be effective and provided a modest positive trend. 


Sign in / Sign up

Export Citation Format

Share Document